AUPM695294A0 - Improved combination therapy dose unit - Google Patents

Improved combination therapy dose unit

Info

Publication number
AUPM695294A0
AUPM695294A0 AUPM6952A AUPM695294A AUPM695294A0 AU PM695294 A0 AUPM695294 A0 AU PM695294A0 AU PM6952 A AUPM6952 A AU PM6952A AU PM695294 A AUPM695294 A AU PM695294A AU PM695294 A0 AUPM695294 A0 AU PM695294A0
Authority
AU
Australia
Prior art keywords
combination therapy
dose unit
improved combination
therapy dose
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPM6952A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOORE T
Original Assignee
MOORE T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MOORE T filed Critical MOORE T
Priority to AUPM6952A priority Critical patent/AUPM695294A0/en
Publication of AUPM695294A0 publication Critical patent/AUPM695294A0/en
Priority to PCT/AU1995/000434 priority patent/WO1996002236A1/en
Priority to AU29184/95A priority patent/AU2918495A/en
Assigned to BORODY, THOMAS JULIUS, MOORE, TREVOR reassignment BORODY, THOMAS JULIUS Change of Name of Applicant under S 104 Assignors: MOORE, TREVOR
Assigned to BORODY, THOMAS JULIUS, MOORE, TREVOR reassignment BORODY, THOMAS JULIUS Amend patent request/document other than specification (104) Assignors: MOORE, TREVOR
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/10—Complex coacervation, i.e. interaction of oppositely charged particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
AUPM6952A 1994-07-20 1994-07-20 Improved combination therapy dose unit Abandoned AUPM695294A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPM6952A AUPM695294A0 (en) 1994-07-20 1994-07-20 Improved combination therapy dose unit
PCT/AU1995/000434 WO1996002236A1 (en) 1994-07-20 1995-07-18 Improved combination dose unit
AU29184/95A AU2918495A (en) 1994-07-20 1995-07-18 Improved combination dose unit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM6952A AUPM695294A0 (en) 1994-07-20 1994-07-20 Improved combination therapy dose unit

Publications (1)

Publication Number Publication Date
AUPM695294A0 true AUPM695294A0 (en) 1994-08-11

Family

ID=3781482

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPM6952A Abandoned AUPM695294A0 (en) 1994-07-20 1994-07-20 Improved combination therapy dose unit

Country Status (2)

Country Link
AU (1) AUPM695294A0 (en)
WO (1) WO1996002236A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2194100T3 (en) 1995-05-09 2003-11-16 Phoqus Ltd ELECTROSTATIC COATING.
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9600071D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
WO1998023272A1 (en) * 1996-11-27 1998-06-04 The Procter & Gamble Company Compositions and methods for the treatment of gastrointestinal disorders
US5753711A (en) * 1997-03-18 1998-05-19 Collagenex Pharmaceuticals, Inc. Method for treatment of H. pylori
IT1296980B1 (en) 1997-12-17 1999-08-03 Istituto Pirri S R L DOUBLE CAPSULE AS A PHARMACEUTICAL FORM FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS IN MULTIPLE THERAPIES
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2011342368B2 (en) 2010-12-13 2016-11-17 Rite-Prep Pty Ltd Gastric and colonic formulations and methods for making and using them
EP2601947A1 (en) * 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
DK2877163T3 (en) 2012-07-27 2019-04-15 Redhill Biopharma Ltd FORMULATIONS AND PROCEDURES FOR THE PREPARATION OF FORMS FOR USING GAS DRAINAGE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2927249A1 (en) * 1978-07-07 1980-01-17 Sinloihi Co Ltd FINE SPHERICAL POLYMER PARTICLES CONTAINING AN INORGANIC PIGMENT AND / OR A BLACK COLORANT, AND METHOD FOR THE PRODUCTION THEREOF
JPS5659802A (en) * 1979-10-23 1981-05-23 Shinroihi Kk Microspherical polymer particle and production thereof
US4565764A (en) * 1982-09-10 1986-01-21 Canon Kabushiki Kaisha Microcapsule toner and process of making same
AU623868B2 (en) * 1987-10-12 1992-05-28 Capability Services Pty. Limited Improved method for treatment of gastrointestinal disorders
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate

Also Published As

Publication number Publication date
WO1996002236A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
AU2805195A (en) Therapeutic compounds
GB9421709D0 (en) Therapeutic compounds
IL115310A0 (en) Combination therapy for hypercholesterolemia
AU3401895A (en) Spiro-azabicyclic compounds useful in therapy
AP2002002661A0 (en) Combination therapy for oesteoporosis
ZA9533B (en) Pentolifylline therapy
AUPM695294A0 (en) Improved combination therapy dose unit
EP0844969A4 (en) Unit dose assembly
AU3118697A (en) Radiation therapy dose calculation engine
GB2280036B (en) Therapy tomograph
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
GB9524942D0 (en) Drug therapy
AU5330198A (en) Therapeutic compounds
AU2918495A (en) Improved combination dose unit
AU1714195A (en) Therapeutic benzonitriles
AUPM469794A0 (en) Therapeutic compounds
AUPM344694A0 (en) Therapeutic compounds
AUPM344794A0 (en) Therapeutic compounds
AUPM489594A0 (en) Therapeutic compounds
AU127607S (en) Unit dose inhaler
GB9505272D0 (en) Combination therapy
AUPM656394A0 (en) Therapeutic agents
AUPM983594A0 (en) Therapeutic agent
AUPM971494A0 (en) Therapeutic agent
GB9416632D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104